Simo Huang, MD
Dermatopathology · Bellaire, TXNPI 1346730066
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,428 of the $5,211 with a category attached, or 85.0%. It is spread thinly across 23 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,213 and has fallen 73.5% since, to $321 in 2025.
Across 162 payments — averaging $32.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$1K
- Janssen Scientific Affairs, LLC$1K
- AbbVie$529
- Sanofi$373
- LEO Pharma Inc.$307
- E.r. Squibb & Sons, L.L.C.$267
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,42885%
- Education$78315%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 62 | $1,227 |
| Janssen Scientific Affairs, LLC | 10 | $1,122 |
| AbbVie | 30 | $529 |
| Sanofi | 9 | $373 |
| LEO Pharma Inc. | 15 | $307 |
| E.r. Squibb & Sons, L.L.C. | 3 | $267 |
| Novartis | 2 | $175 |
| Lilly USA, LLC | 3 | $166 |
| Helsinn Therapeutics (U.S.), Inc. | 3 | $146 |
| UCB, Inc. | 2 | $145 |
| Incyte Corporation | 5 | $140 |
| Regeneron Healthcare Solutions, Inc. | 3 | $111 |
| Journey Medical Corporation | 1 | $95 |
| Pfizer | 1 | $84 |
| Dermavant Sciences, Inc. | 4 | $75 |
| Sanofi-aventis U.S. LLC | 1 | $72 |
| Revance Therapeutics, Inc. | 1 | $49 |
| Amgen | 2 | $35 |
| Springworks Therapeutics, Inc. | 1 | $32 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Boehringer Ingelheim | 1 | $14 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| Organon | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,211 in reported general payments places this provider in the 60th percentile of 54 dermatopathology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 28 | $125,261 |
| Dupixent SyringeDupilumab | 13 | $48,738 |
| Clobetasol Propionate | 118 | $5,176 |
| Doxycycline Hyclate | 36 | $439 |
| Triamcinolone Acetonide | 45 | $431 |
| Ketoconazole | 24 | $401 |
| Terbinafine Hcl | 18 | $370 |
| ValacyclovirValacyclovir Hcl | 14 | $243 |
| Minoxidil | 20 | $232 |
| Mupirocin | 26 | $189 |
| Hydrocortisone | 36 | $176 |
| Gabapentin | 11 | $29 |
Paid to pharmacies, not to this prescriber.
Other dermatopathology in Bellaire
- Angela MooreArlington$423K
- Melissa ChiangSpring$163K
- Alde GavinoLiberty Hill$110K
- Clay CockerellDallas$40K
- Michael TetzlaffHoustion$38K
- Matthew PetittPasadena$23K
- Miranda EwelukwaSugar Land$22K
- Ronald HarrisAustin$14K
- Andrew FischerHouston$11K
- Titilola SodeDallas$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.